跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FERAHEME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FERAHEME
Authorized
STANDARD
FERAHEME
AMAG PHARMACEUTICALS, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
abc2b4752480d7c2
Company
AMAG PHARMACEUTICALS, INC.
Type
Standard
Approval Details
Approval Id
abc2b4752480d7c2
Drug Approval Canada Name
FERAHEME
Product Name
FERAHEME
Status
Cancelled Post Market
Status Date
2016-09-26
Original Market Date
2012-05-01
Din
02377217
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:04.04
Atc Original
B03AC IRON, PARENTERAL PREPARATIONS
Atc Name
b 03 ac
Aig Number
0108536002
Company Name
AMAG PHARMACEUTICALS, INC.
Company Address
1100 Winter Street, Waltham, Massachusetts, United States, 02415
Company Detail Path
/organization/amag-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
AMAG PHARMACEUTICALS, INC.
Country Name
United States
Province Name
Massachusetts
City Name
马萨诸塞州米德尔塞克斯县
Address
61 Mooney St
Website
http://www.amagpharma.com
Active Ingredients
IRON (FERUMOXYTOL)
30 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
abc2b4752480d7c2
Type
Standard
Back to Health Canada Approvals